跳至主要内容
临床试验/ITMCTR2000003828
ITMCTR2000003828尚未招募1 期

A single center, randomized controlled trial on the treatment of elderly patients with acute myeloid leukemia by attack and reinforcement combined with demethylation

Yueyang integrated traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
60 至 80(—)
性别
All

入选标准

  • 1. Meet the diagnostic criteria of Western medicine for senile AML;
  • 2. Accord with the diagnostic criteria of TCM syndrome of senile AML;
  • 3. Aged 60 to 80 years old;
  • 4. The patients with an estimated survival time of more than 3 months;
  • 5. Willing to accept the treatment of this program and sign the informed consent.

排除标准

  • 1. Acute promyelocytic leukemia;
  • 2. Patients with serious organic diseases such as heart, brain, liver and kidney, and patients with other malignant tumors and mental diseases;
  • 3. Coexisting diseases with any significant abnormalities or poor nutritional status, which affect the life safety and compliance of patients;
  • 4. Allergy to any drug involved in the scheme;
  • 5. Participate in other clinical researchers one month before enrollment.

研究者

发起方
Yueyang integrated traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of traditional Chinese Medicine

相似试验